Surgery is supposed to fix a problem, not create a new one in the brain. Yet for some patients—particularly those with chronic obstructive pulmonary disease (COPD)—the days and weeks after an operation can bring a quiet, frustrating fog: misplaced keys, lost words, a mind that feels a half-step behind. This is postoperative cognitive dysfunction (POCD) , and COPD makes it substantially more likely.

What POCD Actually Is—and Is Not

POCD is a decline in memory, attention, executive function, and processing speed that emerges after surgery and anesthesia. It is distinct from postoperative delirium, which is an acute, fluctuating confusional state that typically appears within days of surgery. POCD, by contrast, has a more insidious onset and can persist for weeks or months, interfering with work, independence, and quality of life. In older adults undergoing major noncardiac surgery, early POCD can affect anywhere from 30% to 80% of patients, depending on how strictly it is defined and measured.

The brain does not have a single “POCD switch.” The dominant theory is that neuroinflammation serves as a final common pathway: surgical trauma and anesthesia trigger a peripheral inflammatory response that crosses into the central nervous system, activating microglia and disrupting hippocampal function. Add hypoxia, blood-brain barrier disruption, and the vulnerability of an aging brain, and the conditions for cognitive decline are set.

Why COPD Raises the Stakes

COPD is not merely a disease of the airways. It is a systemic inflammatory condition that keeps the body in a low-grade state of immune activation long before the patient ever reaches the operating room. That baseline matters enormously.

The lung–brain axis is already under strain. A 2025 review in the International Journal of Biological Sciences describes how oxidative stress and inflammatory mediators generated in COPD lungs spill into the systemic circulation, increase blood–brain barrier permeability, and contribute to neuronal dysfunction and glial changes. In other words, the brain of a COPD patient is not starting from neutral; it is already receiving inflammatory and oxidative “signals” from the lungs.

Hypoxia is the second hit. COPD patients are prone to low oxygen levels, and the perioperative period—anesthesia, sedation, recovery—adds further episodes of hypoxemia. Brain regions responsible for memory and attention are exquisitely sensitive to oxygen deprivation. One analysis found that in COPD patients with hypoxemia, the incidence of cognitive impairment reaches as high as 77%. When oxygen saturation falls, the brain pays a price that can outlast the surgery itself.

Smoking adds an independent layer of risk. Many COPD patients have a significant smoking history, and smoking itself has been identified as a likely independent risk factor for early POCD, with proposed mechanisms involving chronic inflammation, mast cell activation, and cholinergic pathways. COPD and smoking are not perfectly overlapping, but where they converge, the cognitive risk compounds.

Clinical data reflect this. A prospective study of patients aged 45 to 75 found that the presence of COPD correlated negatively with postoperative memory scores—patients with COPD before surgery showed diminished cognitive ability afterward. COPD has also been flagged in multiple reviews as a comorbidity that increases POCD vulnerability, alongside advanced age, pre-existing cognitive impairment, and diabetes.

What Can Be Done: A Window for Protection

The most important message for patients and families is that COPD-related POCD risk is not a reason to avoid necessary surgery—it is a reason to plan more carefully.

Preoperative optimization buys brain reserve. Before elective surgery, lung function should be stabilized, inhaler therapy reviewed, and oxygenation optimized. In COPD patients, preoperative preoxygenation with non-invasive ventilation or high-flow nasal cannula can maximize pulmonary reserve and reduce perioperative hypoxemia. Treating COPD optimally before surgery is, in effect, treating the brain protectively.

Anesthetic choices matter. Regional anesthesia—spinal, epidural, or peripheral nerve blocks—is generally preferred over general anesthesia in COPD patients when feasible, and can reduce postoperative pulmonary complications by up to 50%. When general anesthesia is necessary, protective ventilation strategies and avoidance of excessive anesthetic depth are priorities. Dexmedetomidine, a sedative with anti-inflammatory properties, has been associated with reduced POCD incidence in older surgical patients, particularly in regional anesthesia and sedation contexts.

The postoperative period is not passive. Early mobilization, adequate pain control, avoidance of unnecessary sedatives, and prompt restoration of normal sleep–wake rhythms all support cognitive recovery. For COPD patients, maintaining oxygen saturation and preventing postoperative pulmonary complications are inseparable from protecting the brain.

The Bottom Line

COPD and POCD are connected by a believable, biologically grounded pathway: a chronically inflamed and oxygen-starved body, subjected to the additional stress of surgery and anesthesia, produces a brain that struggles to bounce back. The connection is not destiny, but it is a signal. For COPD patients facing surgery, the question is not whether the brain is at risk—it is whether the perioperative team is treating the lungs and the brain as two ends of the same problem. Increasingly, the evidence says they should be.